Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics

It is believed that genetic factors, immune system dysfunction, chronic inflammation, and intestinal microbiota (IM) dysbiosis contribute to the pathogenesis of colorectal cancer (CRC). The beneficial role played by the direct regulation of IM in inflammatory bowel disease treatment is identified by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Chenbo, Tang, Wendong, Fan, Xiaobo, Wu, Guoqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097518/
https://www.ncbi.nlm.nih.gov/pubmed/30147331
http://dx.doi.org/10.2147/OTT.S170626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097518/
https://www.ncbi.nlm.nih.gov/pubmed/30147331
http://dx.doi.org/10.2147/OTT.S170626

Ejemplares similares